Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Boceprevir> ?p ?o. }
Showing items 1 to 74 of
74
with 100 items per page.
- Boceprevir abstract "Boceprevir (INN, trade name Victrelis) is a protease inhibitor used as a treatment for hepatitis C genotype 1. It binds to HCV nonstructural 3 NS3 (HCV) active site.It was being developed by Schering-Plough, but is now being developed by Merck since Schering was acquired in 2009. It was approved by the FDA on May 13, 2011.".
- Boceprevir atcPrefix "J05".
- Boceprevir atcSuffix "AE12".
- Boceprevir casNumber "394730-60-0".
- Boceprevir fdaUniiCode "89BT58KELH".
- Boceprevir iupacName "(1R,5S)-N-[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2(S)-carboxamide".
- Boceprevir pubchem "10324367".
- Boceprevir thumbnail Boceprevir.svg?width=300.
- Boceprevir wikiPageID "17145945".
- Boceprevir wikiPageRevisionID "605711199".
- Boceprevir atcPrefix "J05".
- Boceprevir atcSuffix "AE12".
- Boceprevir c "27".
- Boceprevir casNumber "394730".
- Boceprevir chembl "218394".
- Boceprevir chemspiderid "8499830".
- Boceprevir eliminationHalfLife "12240.0".
- Boceprevir h "45".
- Boceprevir hasPhotoCollection Boceprevir.
- Boceprevir inchi "1".
- Boceprevir inchikey "LHHCSNFAOIFYRV-DOVBMPENBP".
- Boceprevir iupacName "-N-[3-Amino-1--2,3-dioxopropyl]-3-[2-[[[amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide".
- Boceprevir legalUs "Rx-only".
- Boceprevir licenceUs "Boceprevir".
- Boceprevir medlineplus "a611039".
- Boceprevir n "5".
- Boceprevir niaidChemdb "398493".
- Boceprevir o "5".
- Boceprevir pregnancyUs "B".
- Boceprevir proteinBound "75.0".
- Boceprevir pubchem "10324367".
- Boceprevir routesOfAdministration "Oral".
- Boceprevir smiles "O=C[C@@H]CC".
- Boceprevir stdinchi "1".
- Boceprevir stdinchikey "LHHCSNFAOIFYRV-DOVBMPENSA-N".
- Boceprevir tradename "Victrelis".
- Boceprevir unii "89".
- Boceprevir verifiedrevid "461592659".
- Boceprevir watchedfields "changed".
- Boceprevir width "240".
- Boceprevir subject Category:Anti-RNA_virus_drugs.
- Boceprevir subject Category:Hepatitis_C.
- Boceprevir subject Category:Protease_inhibitors.
- Boceprevir type Agent114778436.
- Boceprevir type Antiviral102725367.
- Boceprevir type CausalAgent100007347.
- Boceprevir type Drug103247620.
- Boceprevir type Matter100020827.
- Boceprevir type Medicine103740161.
- Boceprevir type PhysicalEntity100001930.
- Boceprevir type ProteaseInhibitor104013993.
- Boceprevir type ProteaseInhibitors.
- Boceprevir type Substance100020090.
- Boceprevir type Drug.
- Boceprevir type DrugProduct.
- Boceprevir type FunctionalSubstance.
- Boceprevir comment "Boceprevir (INN, trade name Victrelis) is a protease inhibitor used as a treatment for hepatitis C genotype 1. It binds to HCV nonstructural 3 NS3 (HCV) active site.It was being developed by Schering-Plough, but is now being developed by Merck since Schering was acquired in 2009. It was approved by the FDA on May 13, 2011.".
- Boceprevir label "Boceprevir".
- Boceprevir label "Boceprevir".
- Boceprevir label "Boceprevir".
- Boceprevir label "Boceprevir".
- Boceprevir label "Bocéprévir".
- Boceprevir sameAs Boceprevir.
- Boceprevir sameAs Boceprevir.
- Boceprevir sameAs Bocéprévir.
- Boceprevir sameAs Boceprevir.
- Boceprevir sameAs Boceprevir.
- Boceprevir sameAs m.043p8j0.
- Boceprevir sameAs Q410551.
- Boceprevir sameAs Q410551.
- Boceprevir sameAs Boceprevir.
- Boceprevir wasDerivedFrom Boceprevir?oldid=605711199.
- Boceprevir depiction Boceprevir.svg.
- Boceprevir isPrimaryTopicOf Boceprevir.